Pricing

RARE Hospitality International, Inc. (RARE)

followers ·
Sector:
CONSUMER DISCRETIONARY
Industry:
RESTAURANTS
SIC:
RETAIL-EATING PLACES
CEO:
Emil D. Kakkis
Employees:
1310
60 LEVERONI COURT, NOVATO, CA, 94949
415-483-8800

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Are you looking for these stocks instead?

Stock Split History
DateRatio
2003-09-03 3:2
Ultragenyx Pharmaceutical Inc. focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the. treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available